10
Participants
Start Date
September 15, 2019
Primary Completion Date
March 14, 2020
Study Completion Date
June 30, 2020
Apremilast;Apremilast;Apremilast 10 MG; 20 MG; 30 MG Oral Tablet
"The study patients will be treated with oral apremilast, administered initially a dose of 10 mg once daily, gradually increasing to reach the maximal therapeutic dosage of 30 mg twice daily before end of 1st week of starting the therapy.~The treatment will be continued till 6 months and we will taper the steroids by 10mg/ 2 weeks till 20mg and then 5 mg/ 2 weeks till discontinuation of steroids.~If a patient worsens after treatment or develops any serious adverse event after initiation of treatment, he will be withdrawn from the study.~If there is no response to the treatment and we are unable to taper steroids after 12 weeks of therapy then the patient will be withdrawn from the study"
Dermatology OPD, New OPD Building, Level 5C, Postgraduate Institute of Medical Education and Research, Chandigarh
PGIMER, Chandigarh
Tarun Narang, Chandigarh
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER